Coronary Angioplasty with Sirolimus Eluting Stents

At present, most percutaneous coronary intervention procedures (PCI) are done with drug eluting stents (DES). However, drug coated balloons (DCB) have shown benefits in restenosis and small vessel de novo lesions. 

Intravascular ultrasound (IVUS) has been shown effective in left main PCI and complex procedures, even though there is little infomration on its use for PCIs with DCB. 

The ULTIMATE III is a clinical randomized controlled open study comparing IVUS guided against angiography guided PCI in patients at high risk of bleeding.

The study included 260 patients with ≤15 mm, 2 to 4 mm in diameter lesions.

Primary end point was late lumen loss (LLL) at 7 months. Patient groups were similar as to demographic and clinical characteristics: mean age 67, 80% were men, 72% were hypertensive, 30% diabetic, 9% had a history of MI, 17% prior PCI, 9% ictus, 5% peptic ulcer, 12% atrial fibrillation, 45% anemia, 10% <100,000 platelet count and 14% kidney function deterioration. 

Read also: Patients with CABG History and new N-ST ACS: Routine Invasive Strategy?

The most frequent clinical presentation was unstable angina (73%), followed by stable chronic angina (14%), and less frequently ST elevation acute myocardial infarction (STEMI), non-ST elevation acute MI (NSTEMI), and silent ischemia. 

There were no differences in lesion localization, the anterior descending being the most affected, followed by the circumflex. Neither were there significant differences in procedure. 

Primary end point resulted favorable for patients receiving IVUS guided PCI (0.03±0.52 mm for ANGIO PCI vs. 0.10±0.34 mm for IVUS PCI; mean difference 0.14 mm; CI 95%: 0.02-0.26; P = 0.025). Also, IVUS PCI was associated with less stenosis (28.15%±13.88% vs. 35.83%±17.69%; P = 0.001) and larger intraluminal diameter (2.06±0.62 mm vs. 1.75±0.63 mm; P < 0.001).

Conclusion

This study has shown IVUS guided PCI is associated with less late lumen loss in patients with de novo coronary lesions vs. angiography guided PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular Ultrasound vs Angiography- Guided Drug-Coated Balloon Angioplasty. 

Reference: The ULTIMATE III Trial. Xiao-Fei Gao, et al. J Am Coll Cardiol Intv 2024. Article in Press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...